Acadian Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-105,777
| Closed | -$1.39M | – | 2227 |
|
|
2024
Q3 | $1.39M | Sell |
105,777
-217,398
| -67% | -$2.85M | ﹤0.01% | 848 |
|
|
2024
Q2 | $3.9M | Sell |
323,175
-279,139
| -46% | -$3.37M | 0.01% | 568 |
|
|
2024
Q1 | $9.79M | Sell |
602,314
-200,067
| -25% | -$3.25M | 0.03% | 303 |
|
|
2023
Q4 | $5.47M | Sell |
802,381
-8,880
| -1% | -$60.5K | 0.02% | 423 |
|
|
2023
Q3 | $4.42M | Buy |
811,261
+157,173
| +24% | +$856K | 0.02% | 478 |
|
|
2023
Q2 | $4.44M | Buy |
654,088
+254,506
| +64% | +$1.73M | 0.02% | 489 |
|
|
2023
Q1 | $2M | Buy |
399,582
+201,022
| +101% | +$1.01M | 0.01% | 714 |
|
|
2022
Q4 | $968K | Buy |
+198,560
| New | +$968K | ﹤0.01% | 856 |
|